We register pharmaceutical products in foreign countries as per the demand of the market and as per our distributors and buyers in foreign countries.  Our company is an exclusive buyer of Indian pharmaceutical manufacturing companies Ruan Life Sciences pvt ltd, Britannia Biological LLP, Rambarg Laboratories Pvt Ltd and Barrco Healthcare, a concern of Barrco Group Corporation, USA, which supplies pharmaceutical and nutraceutical products from Europe and USA. We have our buyers in foreign countries, whom we supply products for distribution of products registered by us in those countries

Mission Statements:
Focus on patient health: Prioritizing the well-being of patients by providing high-quality, safe, and effective medicines.
Meeting customer needs: Ensuring customer satisfaction through tailored solutions, reliable supply, and efficient service.
Innovation and quality: Striving for excellence in pharmaceutical manufacturing through advanced technology, quality standards, and a commitment to ongoing improvement.
Global accessibility: Making advanced and effective treatments available to patients globally, often focusing on regions with specific needs or challenges.
Ethical and transparent practices: Conducting business with honesty, integrity, and transparency to build trust with all stakeholders.

Vision Statements:
Global leadership: Aspiration to be a leading pharmaceutical company recognized internationally for innovation, quality, and impact.
Global impact: Aiming to improve the health of people worldwide through innovative and effective pharmaceutical solutions.
Market leadership: Seeking to become a dominant player in both domestic and international markets.
Partner of choice: Striving to be a trusted and preferred partner for innovative pharmaceutical companies seeking to expand into new markets.
Sustainable growth: Focusing on long-term sustainable growth by developing high-quality products, fostering innovation, and cultivating strong partnerships.

Company’s operating model
The model based on focusing on efficiently moving drugs from manufacturing to patients. Our operating model is flexible and adaptable to changing market conditions and regulatory requirements. It prioritizes efficiency, quality, and safety to ensure that patients receive the drugs they need.

1. R&D and Development:

Focus: Market analyses and register new drugs in our market as per the market demand.
Operating Model: consolidate decision-making bodies and integrating market reviews and analyses and to provide the market needs.

2. Manufacturing and Supply Chain:

Focus: Ensuring the efficient and cost-effective production and delivery of drugs.
Operating Model: Our decentralized approach allows us to source essential pharmaceutical and nutraceutical products from multiple manufacturers in India, Europe and the USA.

3. Commercial Operations:

Focus: Bringing products to market and ensuring successful sales and distribution.
Operating Model: market research, marketing strategies, and sales efforts to effectively reach target markets.

4. Key Considerations for Operating Model Design:

Organizational Strategy: We align the operating model with our overall strategic goals.
Team Size and Spend: Determining the best structure for managing resources and costs.
Geographic Complexity: we adapt the operating model to different regions and markets.
Supplier Landscape: We manage relationships with suppliers and ensuring quality and reliability.
Category Management: Optimizing purchasing and spending for different categories of goods and services.
Risk Management: Identifying and mitigating potential risks in the supply chain and operations.
Stakeholder Alignment: Ensuring that all stakeholders (employees, customers, suppliers) are aligned with the operating model.